ABUS · Categories · Form 4

ABUS - SEC Form 4 insider transactions

Arbutus Biopharma Corporation (ABUS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ABUS

• 126d
  Chief Financial Officer Nguyen Tuan was granted 73,500 shares (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 126d
  President and CEO Androski Lindsay was granted 28,000 shares (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 306d
  SEC Form 4 filed by Director Sawhney Roger

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 433d
  Amendment: SEC Form 4 filed by Chief Financial Officer Nguyen Tuan

  4/A - Arbutus Biopharma Corp (0001447028) (Issuer)
• 434d
  SEC Form 4 filed by Chief Financial Officer Nguyen Tuan

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 445d
  SEC Form 4 filed by Director Hasija Anuj

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 445d
  SEC Form 4 filed by Director Beardsley Robert A

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 445d
  SEC Form 4 filed by President and CEO Androski Lindsay

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 474d
  General Counsel and CCO Naftzger J. Christopher was granted 54,300 shares, increasing direct ownership by 63% to 140,544 units (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 474d
  Interim President & CEO Mcelhaugh Michael J. was granted 177,000 shares, increasing direct ownership by 12% to 1,658,003 units (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 474d
  Chief Financial Officer Hastings David C was granted 90,100 shares, increasing direct ownership by 56% to 249,824 units (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 474d
  Chief Medical Officer Sims Karen was granted 49,300 shares, increasing direct ownership by 46% to 155,494 units (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 488d
  Chief Financial Officer Hastings David C sold $72,827 worth of shares (22,183 units at $3.28), decreasing direct ownership by 12% to 159,724 units (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 488d
  Chief Medical Officer Sims Karen sold $63,519 worth of shares (19,348 units at $3.28), decreasing direct ownership by 15% to 106,194 units (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 488d
  Interim President & CEO Mcelhaugh Michael J. sold $78,103 worth of shares (23,790 units at $3.28), decreasing direct ownership by 2% to 1,481,003 units (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 488d
  General Counsel and CCO Naftzger J. Christopher sold $37,206 worth of shares (11,333 units at $3.28), decreasing direct ownership by 12% to 86,244 units (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 661d
  Director Manchester Keith S exercised 54,915 shares at a strike of $0.56 and sold $32,637 worth of shares (8,846 units at $3.69) (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 745d
  SEC Form 4 filed by Burgess Daniel D

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 745d
  SEC Form 4 filed by Manchester Keith S

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 745d
  SEC Form 4 filed by Henriques Richard C Jr

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 745d
  SEC Form 4 filed by Meyers James R

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 745d
  SEC Form 4 filed by Rewolinski Melissa

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 745d
  SEC Form 4 filed by Torti Frank

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 854d
  Naftzger J. Christopher was granted 95,100 shares (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 854d
  Sims Karen was granted 101,000 shares and sold $10,078 worth of shares (4,358 units at $2.31), increasing direct ownership by 334% to 125,542 units (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 854d
  Hastings David C was granted 112,500 shares and sold $22,184 worth of shares (9,593 units at $2.31), increasing direct ownership by 130% to 181,907 units (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 854d
  Sofia Michael J. was granted 109,500 shares and sold $23,083 worth of shares (9,982 units at $2.31), increasing direct ownership by 7% to 1,485,121 units (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 854d
  Mcelhaugh Michael J. was granted 123,800 shares and sold $23,504 worth of shares (10,164 units at $2.31), increasing direct ownership by 8% to 1,504,793 units (SEC Form 4)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1061d
  SEC Form 4 filed by Rewolinski Melissa

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1062d
  SEC Form 4 filed by Sims Karen

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1062d
  SEC Form 4 filed by Naftzger J. Christopher

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1109d
  SEC Form 4 filed by Henriques Richard C Jr

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1109d
  SEC Form 4 filed by Manchester Keith S

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1109d
  SEC Form 4 filed by Torti Frank

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1109d
  SEC Form 4 filed by Meyers James R

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1221d
  SEC Form 4: Mcelhaugh Michael J. was granted 83,700 shares, increasing direct ownership by 6% to 1,391,157 units (withholding tax)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1221d
  SEC Form 4: Sofia Michael J. was granted 82,200 shares, increasing direct ownership by 6% to 1,385,603 units (withholding tax)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1221d
  SEC Form 4: Hastings David C was granted 79,000 shares (withholding tax)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1221d
  SEC Form 4: Collier William H. was granted 216,500 shares (tax liability)

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1221d
  SEC Form 4: Howard Elizabeth was granted 69,700 shares, increasing direct ownership by 427% to 86,024 units to cover taxes

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1474d
  SEC Form 4 filed by Henriques Richard C Jr

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1474d
  SEC Form 4 filed by Meyers James R

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1474d
  SEC Form 4 filed by Tran Tram

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1474d
  SEC Form 4 filed by Burgess Daniel D

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1474d
  SEC Form 4 filed by Torti Frank

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1600d
  SEC Form 4 filed by Collier William H.

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1600d
  SEC Form 4 filed by Hastings David C

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1600d
  SEC Form 4 filed by Howard Elizabeth

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1600d
  SEC Form 4 filed by Sofia Michael J.

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1600d
  SEC Form 4 filed by Mcelhaugh Michael J.

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1600d
  SEC Form 4 filed by Picchio Gaston

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1648d
  SEC Form 4: Sofia Michael J. sold $1,018,000 worth of shares (200,000 units at $5.09) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 1,303,403 units

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1669d
  SEC Form 4 filed by Tran Tram

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1827d
  SEC Form 4 filed by BURGESS DANIEL D

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1827d
  SEC Form 4 filed by Meyers James R

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1827d
  SEC Form 4 filed by HENRIQUES RICHARD C JR

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1827d
  SEC Form 4 filed by Arbutus Biopharma Corporation

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1827d
  SEC Form 4 filed by Arbutus Biopharma Corporation

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1827d
  SEC Form 4 filed by Arbutus Biopharma Corporation

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)
• 1937d
  SEC Form 4 filed by Gaston Picchio

  4 - Arbutus Biopharma Corp (0001447028) (Issuer)

Other ABUS categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends